eighteen
mous
ascit
fluid
contain
monoclon
antibodi
mab
direct
crystal
hexon
adenoviru
av
type
use
map
antigen
structur
capsom
reciproc
competit
bind
elisa
help
peroxidaselabel
mab
least
nine
epitop
epitop
cluster
locat
three
distinct
antigen
site
identifi
hexon
epitop
antigen
site
recogn
two
mab
could
genu
specif
antigen
determin
base
broad
reactiv
pattern
mab
epitop
antigen
site
ii
recogn
fifteen
mab
could
divid
seven
epitop
cluster
accord
competit
pattern
antigen
site
iii
recogn
one
mab
complet
differ
antigen
site
basi
oneway
block
mab
specif
antigen
site
ii
also
differ
latter
one
data
suggest
seven
epitop
cluster
antigen
site
ii
contain
partial
overlap
epitop
may
part
larg
singl
immunodomin
antigen
region
av
hexon
well
hexon
heterolog
type
monoclon
antibodi
proven
use
tool
determin
import
antigen
region
structur
viru
protein
introduct
mab
antigen
analysi
adenoviru
hexon
protein
result
recognit
capsom
complic
antigen
structur
known
earlier
use
panel
mab
produc
crystal
av
hexon
examin
purifi
heterolog
hexon
demonstr
surfac
hexon
larg
number
epitop
exist
overlap
character
interspeei
speeifieiti
present
paper
report
delin
differ
antigen
site
epitop
epitop
cluster
adenoviru
hexon
mean
competit
bind
elisa
human
adenoviru
type
subgenu
c
subgenu
subgenu
subgenu
b
use
experi
determin
crossreact
mab
strain
propag
cell
solubl
hexon
protein
viru
type
separ
purifi
describ
earlier
spleen
cell
balbc
mice
immun
crystal
av
hexon
fuse
sp
myeloma
cell
hybrid
cell
produc
specif
mab
inocul
ip
mice
develop
ascit
suck
abdomen
reactiv
pattern
mab
determin
differ
hexon
type
use
indirect
elisa
satur
ammonium
sulphat
ad
ascit
fluid
final
concentr
per
cent
centrifug
g
minut
pellet
resuspend
per
cent
satur
ammonium
sulphat
three
time
repeat
centrifug
pellet
resuspend
distil
water
dialys
pb
ph
c
overnight
mab
dimys
label
horseradish
peroxidas
ieanal
budapest
accord
techniqu
avnemea
terynck
briefli
mg
peroxidas
dissolv
ml
phosphat
buffer
ph
contain
per
cent
glutaraldehyd
incub
room
temperatur
hour
pass
sephadex
column
browneolour
fraction
eollect
ad
mg
mab
mixtur
store
c
hour
dialys
extens
pb
competitivebind
assay
conjug
titrat
direct
elisa
use
competit
experi
predetermin
dilut
result
absorb
approx
measur
nm
polystyren
plate
novogen
coat
purifi
av
hexon
ng
well
pb
ph
overnight
nonspecif
bind
reduc
minimum
addit
pbstween
contain
per
cent
bsa
serva
heidelberg
hour
dilut
untabel
competitor
mab
caus
per
cent
inhibit
label
probe
start
dilut
dilut
factor
serial
twofold
dilut
compctit
mab
ad
follow
immedi
predetermin
dilut
label
mab
plate
incub
minut
c
wash
bound
peroxidaselahel
mab
detect
ad
orthophenylenediamin
opd
reaction
stop
addit
l
per
well
optic
densiti
determin
nm
titertek
multiskan
photomet
sinc
nonspecif
bind
individu
conjug
vari
consider
bind
control
antigen
bsa
taken
repres
background
bind
conjug
viral
antigen
maximum
bind
differ
taken
repres
per
cent
bind
rel
inhibit
compet
first
antibodi
normal
scale
individu
test
result
express
percentag
competit
rate
complet
inhibit
first
three
dilut
caus
per
cent
reduct
absorbane
partial
inhibit
reduct
per
cent
result
consid
neg
reduct
absorb
per
cent
hand
competitivebind
elisa
perform
mixtur
label
mab
design
b
differ
concentr
purifi
hexon
type
preineub
c
hour
well
coat
av
hexon
gml
inhibit
abil
differ
hexon
type
calcul
mention
eighteen
mab
use
unlabel
peroxidselabel
form
differenti
topograph
distinct
antigen
site
av
hexon
terminolog
yewdel
nd
gerhard
use
defin
epitop
antigen
site
ie
antigen
site
consist
cluster
epitop
epitop
combin
site
singl
mab
three
differ
antigen
site
could
separ
basi
reciproc
competit
experi
tabl
epitop
antigen
site
recogn
two
nlab
complet
differ
antigen
site
ii
iii
ie
mab
caus
complet
inhibit
ill
ii
iii
ii
iii
x
recogn
probabl
epitop
antigen
site
mab
could
inhibit
bind
label
mab
specif
antigen
site
ii
iii
fig
mab
specif
antigen
site
ii
inhibit
bind
peroxidas
label
mab
specif
antigen
site
could
caus
complet
partial
inhibit
bind
mab
specif
differ
epitop
cluster
antigen
site
ii
tabl
mab
h
could
inhibit
bind
mab
antigen
site
fig
mab
partial
inhibit
bind
mab
specif
antigen
site
ii
show
oneway
block
pattern
unidireetionm
block
fig
reciproc
bidirect
complet
block
taken
indic
ident
antigen
site
mab
h
probabl
recogn
separ
third
antigen
site
tabl
epitop
antigen
site
ii
could
cluster
seven
group
base
complet
partial
reciproc
inhibit
tabl
mab
epitop
cluster
complet
inhibit
bind
mab
partial
inhibit
bind
mab
specif
epitop
cluster
fig
kind
competit
pattern
could
character
two
larger
group
close
relat
epitop
one
could
epitop
cluster
character
epitop
ii
differenti
epitop
cluster
base
differ
partial
reciproeai
inhibit
mab
group
cluster
mab
epitop
cluster
complet
inhibit
bind
mab
specif
epitop
reciproc
fashion
inhibit
lva
et
tabl
mab
specif
epitop
cluster
complet
inhibit
bind
repres
epitop
cluster
partial
inhibit
bind
mab
specif
epitop
cluster
c
c
c
c
partial
fig
mab
epitop
cluster
show
n
h
e
r
form
reciproc
competit
ie
one
mab
c
partiallyinhibit
bind
three
mab
c
b
latter
three
mab
complet
inhibit
fig
mab
specif
epitop
cluster
show
similar
inhibit
p
e
r
n
epitop
cluster
mean
h
one
mbkb
group
b
could
partial
inhibit
bind
two
mab
c
show
reciproc
partial
inhibit
pattern
two
latter
mab
complet
inhibit
bind
determin
presenc
differ
av
hexon
relat
epitop
heterolog
hexon
type
four
label
mab
b
mix
serial
dilut
gml
differ
hexon
type
preincub
c
l
mixtur
ad
av
hexon
coat
well
absorbane
determin
presenc
absenc
heterolog
hexon
type
type
subgenu
type
seen
case
mab
hexon
type
mix
mab
caus
nearli
per
cent
inhibit
result
type
similar
mix
mab
b
type
could
compet
bind
mab
curv
repres
competit
heterolog
type
subgenu
fig
ac
case
mab
similar
type
subgenu
c
high
concentr
type
mab
b
hexon
type
could
caus
complet
inhibit
even
high
concentr
eighteen
mab
use
unlabel
peroxidasetabel
form
reciproc
competit
bind
elisa
map
antigen
structur
hexon
mab
compar
mab
inhibit
pattern
character
complet
partial
bidireetionm
reciprocm
undireet
oneway
inhibit
least
three
antigen
site
iii
determin
base
result
seven
epitop
cluster
epitop
could
separ
antigeni
site
ii
two
mab
c
specif
antigen
site
recogn
epitop
ie
genu
specif
one
mab
broad
reactiv
pattern
react
hexon
human
av
type
studi
elisa
ha
bovin
av
type
gel
precipit
experi
specif
steric
independ
epitop
compar
mab
h
b
also
demonstr
gel
diffus
experi
mab
h
howev
react
human
av
type
test
fail
react
bovin
av
type
elisa
unpublish
data
well
gel
diffus
experi
mab
inhibit
bind
two
mab
specif
antigen
site
show
unidirect
complet
block
mab
specif
antigen
site
ii
find
suggest
epitop
recogn
mab
h
consid
steriemli
distinct
antigen
determin
site
iii
hand
competitionbind
elisa
show
larg
number
crossreact
epitop
present
adenoviru
hexon
least
seven
epitop
duster
antigen
site
ii
determin
fifteen
mab
show
similar
basi
differ
kind
complet
mutum
unidirect
inhibit
pattern
caus
nonreciproc
unidirect
oneway
inhibit
could
static
chang
epitop
due
attach
mab
prevent
partimli
bind
label
mab
neighbour
epitop
may
locat
groov
surfac
antigen
site
therefor
bind
compet
mab
could
steriemti
block
access
label
llb
specif
differ
epitop
groov
explan
could
differ
due
n
b
avid
analysi
antigen
structur
adenoviru
hexon
lead
two
j
r
conclus
one
hand
nine
epitop
epitop
cluster
identifi
b
eighteen
mab
locat
three
distinct
p
r
e
u
b
l
n
n
v
e
r
l
p
p
n
g
antigen
site
hand
suggest
h
seven
epitop
cluster
identifi
b
fifteen
mab
antigen
site
ii
contain
partial
v
e
r
l
p
p
n
g
epitop
p
r
larg
singl
u
n
n
n
region
av
hexon
well
heterolog
h
e
x
n
type
u
g
g
e
e
e
x
p
e
r
e
n
heterolog
hexon
